BTO_0001948
stringlengths 11
11
| JURKAT E-6.1 cell
stringlengths 2
47
| Human, blood, leukemia, T cell line, clone E6.1.
stringlengths 20
1.28k
|
---|---|---|
EFO_0007073 | CyT49 | This hESC line was isolated using human feeder cells under good manufacturing process (GMP) conditions. NIH registration: 0041. |
EFO_0007074 | DND-41 | DND-41 was established from the peripheral blood of 13-year-old boy with T-acute lymphoblastic leukemia (T-ALL; type III cortical) in 1977; described to carry CDKN2B (p15INK4B) and CDKN2A (p16INK4A) deletions and TP53 (p53)mutation. |
EFO_0007076 | ES-I3 | The I3 stem cell line was derived from donated blastocysts by removal of the trophoblast layer and further culturing of the intact inner cell mass on mitotically inactivated mouse embryonic fibroblast (MEF) feeder cells. Following injection into SCID mice, the I3 line formed teratomas that contained tissues from all three embryonic germ layers. This line exhibits a normal XX karyotype. These cells were provided by Alex Meissner and maintained in mTeSR medium. |
EFO_0007078 | HUES13 | Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium. |
EFO_0007079 | HUES28 | Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vivo (teratoma). The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [PMCID: PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007080 | HUES3 | Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007081 | HUES44 | Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium. |
EFO_0007082 | HUES45 | Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium. |
EFO_0007083 | HUES48 | Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-81. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007084 | HUES49 | Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007085 | HUES53 | Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, TRA1-60, TRA1-81 and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007086 | HUES6 | Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007087 | HUES62 | Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007088 | HUES63 | Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007089 | HUES64 | Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007091 | HUES65 | Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007092 | HUES66 | Human embryonic stem cell line derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-60. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007093 | HUES8 | Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007094 | HUES9 | Human embryonic stem cell line with an abnormal 46XX, Inv9 karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007095 | iPS DF 19.7 | IPS DF 19.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1 |
EFO_0007096 | iPS DF 19.11 | Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium. |
EFO_0007097 | iPS DF 4.7 | IPS DF 4.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1 |
EFO_0007098 | iPS DF 6.9 | Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium. |
EFO_0007099 | iPS-11a | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [90%]; abnormal, extra marker chr [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007100 | iPS-11b | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [95%]; abnormal, 47XY +1 [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007101 | iPS-11c | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [75%]; abnormal, 46 XY del in chr 2 [25%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium. |
EFO_0007102 | iPS-15b | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [55%]; Abnormal, +(1)(q25.3) [40%]; trisomy X, +(1)(q25.3) [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007103 | iPS-17a | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007104 | iPS-17b | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007105 | iPS-18a | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [90%]; Abnormal, 45XO [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007106 | iPS-18b | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007107 | iPS-18c | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007108 | iPS-20b | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XY [90%]; Abnormal, non clonal tetraploid [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium. |
EFO_0007109 | iPS-27b | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Abnormal, 47XX +17, addition to 9 [80%]; Normal, 46XX [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium. |
EFO_0007110 | iPS-27e | Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [95%]; Abnormal, 47XX +17 [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium. |
EFO_0007111 | iPS-5 | This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, MYC, hTERT, and SV40 large T (hTERT and SV40 large T did not integrate). |
EFO_0007112 | Loucy | Loucy was established in 1987 from the peripheral blood of a 38-year-old female patient with T-cell acute lymphoblastic leukemia (T-ALL) obtained two months prior to her death. May be of value in evaluating the role of t(16;20) in the etiology of T-ALL. |
EFO_0007116 | UCSF4 | The hESC line UCSF4 with a normal 46XX karyotype was derived from a blastocyst-stage embryo on human foreskin fibroblasts. |
EFO_0007599 | L1-S8 | L1-S8 is a partially reprogrammed cell line generated from human bone marrow mononuclear cells (BMMCs) after prestimulation with early cytokines (TPO, FL, SCF, IL-3) and transduced with Sendai viruses expressing the four factors OCT4, SOX2, KLF4 and cMYC. It originated from a single colony manually picked and clonal expanded. |
EFO_0007600 | L1-S8R | L1-S8R is a human iPSC line derived from L1-S8 after transduction with lentiviral vector pLM-fSV2A (Papapetrou et al NBT 2011) expressing OCT4, SOX2, KLF4 and cMYC. |
EFO_0007610 | RWPE2 | RWPE-2 cells were derived from RWPE-1 cells (ATCC CRL-11609) by transformation with Ki-ras using the Kirsten murine sarcoma virus (Ki-MuSV). |
EFO_0007611 | SU-DHL-2 | Human anaplastic large cell lymphoma cell line, established from the pleural effusion of a 73-year-old female. Most of these cells were hyperdiploid, with a sharp modal number of 51 chromosomes; occasional cells in the hypertetraploid range were also seen. A minute marker chromosome was consistently observed, and increased numbers of chromosomes were seen in the A, B, C, and F groups |
EFO_0007752 | VCaP | Human prostate cancer cell line. |
EFO_0007950 | GM23338 | Induced pluripotent stem cell line; Participant #1 (hu43860C) in the Personal Genome Project: http://www.personalgenomes.org Fibroblast culture from this same subject from which this cell line was made is GM23248and a matching lymphoblast line from this same subject is GM20431. |
EFO_0007951 | hFib2-iPS4 | This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, c-MYC, hTERT, and SV40 Large T antigen transgenes. Cells express pluripotent markers and have a normal karyotype, 46XY. |
EFO_0007952 | iPS-NIHi11 | Induced pluripotent stem cell line isolated from skin sample AG20443. |
EFO_0007953 | iPS-NIHi7 | Induced pluripotent stem cell line isolated from skin sample AG08395. |
EFO_0009318 | HFFc6 | Human foreskin fibroblast cell line immortalized by infection with retroviral constrcuts that expressed the hTERT open reading frame |
EFO_0009747 | GM25256 | Induced pluripotent stem cell line derived from adult skin (leg) fibroblasts; subject clinically normal; wild-type; FISH test: 46, XY. |
EFO_0010973 | NOZ | A human cancer cell line, derived from ascites of a patient of peritonitis carcinomatosa. The patient was diagnosed with adenocarcinoma tubular ++, moderately differentiated. This cell line was composed of polygonal, spindle and round shaped cells. |
EFO_0022342 | gist882 | Human GIST882 cell line with activating Kit mutation (K643E) |
EFO_0022343 | SH-EP1 cell | Human neuroblastoma cell line, established from brain bone marrow tissue from a 4 years old caucasian white with neuroblastoma |
EFO_0022344 | Val cell | Human B-acute lymphoblastic leukemia (B-ALL) cell derived from the bone marrow of a 50-year-old woman with B-ALL; cells were described in the literature to carry the three-way-translocation t(8;14;18) and to overexpress the BCL2 and MYC genes |
EFO_0022345 | CUTLL1 cell | CUTLL1 is a human T-cell lymphoblastic lymphoma cell line derived from a relapsed patient that harbors a t(7;9)(q34;q34) chromosomal translocation resulting in expression of a TCRB-NOTCH1 fusion transcript and aberrant Notch signaling |
EFO_0022346 | 76N cell | Normal human mammary epithelial cells |
EFO_0022347 | GM07166VA7 cell | SV40 T-antigen transformed derivative of GM07166 NBS1 fibroblast cells. |
EFO_0022348 | 184A1 cell | immortal continuous human mammary epithelial cells |
EFO_0022349 | BL-60 cell | Malignant Burkitt lymphoma cell line BL 60 |
EFO_0022350 | T5-1 | An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen (HLA) |
EFO_0022351 | REN | Pleural epithelioid mesothelioma cell line |
EFO_0022352 | SCC12F2 | Normal human epidermal premalignant keratinocyte-derived cell line |
EFO_0022353 | KMC-1 | cholangiocellular (bile duct) carcinoma cell line |
EFO_0022354 | HBC4 cell | Human breast cancer cell line HBC4 |
EFO_0022355 | MDA-Panc-28 cell | Human pancreatic adenocarcinoma cell line. |
EFO_0022356 | MM1-144 | Human myeloma cell line MM1-144 |
EFO_0022357 | NZG0906 | human glioblastoma primary tumor-derived line cell |
EFO_0022358 | Fuji cells | Human Synovial Sarcoma cell line expressing SYT-SSX2 fusion protein. |
EFO_0022359 | SK-LC-5 | Human lung adenocarcinoma cell line |
EFO_0022360 | WT47 cells | An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen |
EFO_0022361 | NA8-MEL cells | Human melanoma cell line NA8 |
EFO_0022362 | Me67 cells | Human melanoma cell line ME67 |
EFO_0022363 | SLB-1 cells | Homo sapiens T cell, HTLV-1 immortalized |
EFO_0022364 | Mel202 cells | Human uveal melanoma cell line Mel202 |
EFO_0022365 | NK3.3 cell | Human Natural killer cell |
EFO_0022366 | WM852 cell | Human melanoma cell line WM852 |
EFO_0022367 | D04 cell | Human melanoma cell line D04 |
EFO_0022368 | MM415 cell | MM415 human melanoma cell line |
EFO_0022369 | MM485 cell | MM485 human melanoma cell line |
EFO_0022370 | WM1791c cell | Human WM1791c melanoma cells |
EFO_0022371 | PMWK cell | Human PMWK melanoma cells |
EFO_0022372 | UT7 cell | Human megakaryoblastic cell line |
EFO_0022373 | GM09607 cell | ATM-/- fibroblast cell line GM09607 |
EFO_0022389 | ECV304 cell | Human umbilical cord, endothelial ECV304 |
EFO_0022390 | GM03318 cell | Human GM03318 fibroblast obtained from patients with Coffin-Lowry Syndrome (CLS). |
EFO_0022391 | GM02184 cell | Human lymphoblastoid cell line |
EFO_0022392 | GM05849 cell | Human Ataxia telangiectasia fibroblast cell line SV40 transformed. |
EFO_0022393 | MT2 cell | Human T cell, lymphoblast, Human T Lymphotrohpic Virus 1 (HTLV-1) immortalized |
EFO_0022398 | TF1 cell | TF-1 have been derived from a patient with erythroleukaemia. They show complete growth dependency on GM-CSF or IL-3, and carry a homogeneous chromosomal abnormality (54,X). |
EFO_0022399 | AML-193 cell | Human acute monocytic leukemia cell line, established from a 13 years old gir |
EFO_0022400 | NT2-N cell | Human neuronal (NT2N) cells derive from an NT2 human teratocarcinoma cell line |
EFO_0022401 | SK-N-BE(2) cell | The SK-N-BE(2) neuroblastoma cell line was established in November of 1972 from a bone marrow biopsy taken from child with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy |
EFO_0022402 | Saos-2 cell | Homo sapiens SAOS-2 cell line established from primary osteogenic sarcoma |
EFO_0022403 | WS1 cell | WS1 is a fibroblast cell isolated from the skin of a Black female donor |
EFO_0022404 | KM-12C cell | Colorectal carcinoma cell line derived from a primary tumor |
EFO_0022405 | HN-5 Cell | Well-differentiated human squamous carcinoma cell line (LICR-LON-HN5) |
EFO_0022406 | MNT-1 cell | Human melanoma cell line |
EFO_0022407 | AG11395 cell | Human Werner Syndrome (WS) cell line transformed with SV40 |
EFO_0022408 | HBL-1 cell | HBL-1 (aka human is an EBV-negative B-cell lymphoma cell line established from the pleural effusion of a patient with malignant lymphoma, diffuse, large cell. |
EFO_0022409 | REH cell | Human B cell precursor leukemia REH cells |
EFO_0022410 | hTERT-HME1 cell | hTERT-HME1 non-oncogenic immortalized mammary epithelial cell line |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.